Your browser doesn't support javascript.
loading
Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors.
Keam, Bhumsuk; Kang, Chang Kyung; Jun, Kang Il; Moon, Song Mi; Suh, Koung Jin; Lee, Dae-Won; Ock, Chan-Young; Kim, Miso; Choi, Yunhee; Lim, Yoojoo; Lee, Kyung-Hun; Kim, Se Hyun; Kim, Tae Min; Kim, Tae-Yong; Oh, Do-Youn; Kim, Dong-Wan; Im, Seock-Ah; Lee, Jong Seok; Kim, Eu Suk; Kim, Hong Bin; Kim, Nam-Joong; Kim, Yu Jung; Park, Wan Beom; Oh, Myoung-Don.
Afiliación
  • Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kang CK; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Jun KI; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Moon SM; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Suh KJ; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.
  • Lee DW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.
  • Ock CY; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kim M; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Choi Y; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Lim Y; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Lee KH; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kim SH; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kim TM; Medical Research Collaborating Center, Seoul National University Hospital, Seoul, Republic of Korea.
  • Kim TY; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Oh DY; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kim DW; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Im SA; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Lee JS; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.
  • Kim ES; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kim HB; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kim NJ; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kim YJ; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Park WB; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Oh MD; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
Clin Infect Dis ; 71(2): 422-425, 2020 07 11.
Article en En | MEDLINE | ID: mdl-31680143
ABSTRACT
Among prospectively enrolled adult patients with cancer receiving immune checkpoint inhibitors (ICIs; n = 46) or cytotoxic agents (n = 90), seroprotection and seroconversion rates after seasonal quadrivalent influenza vaccinations were higher with ICI than with cytotoxic chemotherapy. These results support annual influenza vaccinations for cancer patients receiving ICIs. Clinical Trials Registration clinicaltrials.gov (NCT03590808).
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Gripe Humana / Neoplasias Límite: Adult / Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Gripe Humana / Neoplasias Límite: Adult / Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2020 Tipo del documento: Article